Sitemap
- AMD Peer Perspectives
- AMD Peer Perspectives
- Home
- AMD
- AdaptDx
- Why MacuLogix
- Resources
- E-Books
- Marketing Resources
- Practice Materials & Resources
- AdaptDx Pro Accessories
- Research & Publications
- References
- The effects of diabetic retinopathy and pan-retinal photocoagulation on photoreceptor cell function as assessed by dark adaptometry
- Determining optimal test parameters for assessing dark adaptation in people with Intermediate age-related macular degeneration
- Randomized controlled trial of electro-stimulation therapies to modulate retinal blood flow and visual function in retinitis pigmentosa
- Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure
- Association between retinal thickness measured by spectral-domain optical coherence tomography (OCT) and rod-mediated dark adaptation in non-exudative age-related maculopathy
- Impairments in dark adaptation are associated with age-related macular degeneration severity and reticular pseudodrusen
- Dark adaptation during transient hyperglycemia in type 2 diabetes
- Retinal function in relation to improved glycaemic control in type 1 diabetes
- Twelve-month natural history of dark adaptation in patients with AMD
- A short-duration dark adaptation protocol for assessment of age-related maculopathy
- Author response: additional considerations in the utility of dark adaptometry for the diagnosis of age-related macular degeneration
- Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration
- Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy
- Baseline haemoglobin A1c influences retinal function after long-term insulin pump therapy
- Retinal characteristics during 1 year of insulin pump therapy in type 1 diabetes: a prospective, controlled, observational study
- Health conditions linked to age-related macular degeneration associated with dark adaptation
- Peripheral changes associated with delayed dark adaptation in age-related macular degeneration
- Structural changes associated with delayed dark adaptation in age-related macular degeneration
- Dark adaptation changes in highly myopic patients
- Dark adaptation in relation to choroidal thickness in healthy young subjects: a cross-sectional, observational study
- Natural history of rod-mediated dark adaptation over 2 years in intermediate age-related macular degeneration
- Vision-targeted health related quality of life in older adults: patient-reported visibility problems in low luminance activities are more likely to decline than daytime activities
- Visual function in older eyes in normal macular health: association with incident early age-related macular degeneration 3 years later
- Comparison of visual function in older eyes in the earliest stages of age-related macular degeneration to those in normal macular health
- Delayed rod-mediated dark adaptation is a functional biomarker for incident early age-related macular degeneration
- Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health
- Association between visual function and subretinal drusenoid deposits in normal and early age-related macular degeneration eyes
- Prevalence of undiagnosed age-related macular degeneration in primary eye care
- Longevinex® improves human atrophic aged-related macular degeneration (AMD) photoreceptor / retinal pigment epithelium mediated dark adaptation
- Effect of doxycycline vs. placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial
- Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non–high-risk proliferative diabetic retinopathy: a randomized clinical trial
- Relating retinal morphology and function in aging and early to intermediate age-related macular degeneration subjects
- Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus
- Association of low luminance questionnaire with objective functional measures in early and intermediate age-related macular degeneration
- Additional considerations in the utility of dark adaptometry for the diagnosis of age-related macular degeneration
- Decreased visual function scores on a low luminance questionnaire is associated with impaired dark adaptation
- Rod-mediated dark adaptation and macular pigment optical density in older adults with normal maculas
- Reduced central retinal artery blood flow is related to impaired central visual function in retinitis pigmentosa patients
- Longitudinal study of dark adaptation as a functional outcome measure for age-related macular degeneration
- Visual function metrics in early and intermediate dry age-related macular degeneration for use as clinical trial endpoints
- The ARMS2 A69S polymorphism is associated with delayed rod-mediated dark adaptation in eyes at risk for incident age-related macular degeneration
- References
- Videos
- AdaptDx Pro Overview: Breakthrough Eye Care Technology
- Change the Future of Eye Care with AdaptDx Pro
- Meet Theia
- AdaptDx Pro: What are Techs Saying?
- AdaptDx Pro: Upping Your Eye Care Technician’s Game
- AdaptDx Pro: Improving Dark Adaptation Testing for Patients
- AdaptDx Pro: Run Dark Adaptation Tests Any Place, Any Time
- AdaptDx Pro: Empowering Techs as AMD Champions
- Trouble Seeing At Night: More Than Just A Sign of Aging?
- Expanding the Role of Your Technicians Using the AdaptDx Pro
- Embracing New Technology in Eye Care
- Helping You Identify More AMD Patients with AdaptDx Pro
- From AdaptDx Tabletop Device to AdaptDx Pro Headset
- Embracing A New Way of Detecting AMD
- This is the Story of Maculogix
- Dark Adaptation Technology: From Tabletop to Lightweight Headset
- AdaptDx Pro: These Are A Few of My Favorite Things
- Learn How Dark Adaptation Testing Is Changing AMD Detection
- The Value of Early AMD Detection
- Grow Your Practice and Improve Patient Care
- Meet Theia I Breakthrough Eye Care Technology
- AdaptDx – The Tool to Have in Your AMD Practice
- Impaired Dark Adaptation: The Earliest Biomarker of Age-Related Macular Degeneration
- Early Diagnosis is Key for AMD Patients
- AMD Is Not Your Grandparents’ Disease
- Your AMD Patients Deserve This Level Of Care
- Detecting AMD Early and Often
- Don’t Let AMD Diagnosis Be a Shot in the Dark
- Coming Out of the Dark About AMD (Vision Source Exchange 2019)
- AdaptDx permet de diagnostiquer la DMLA à ses stades les plus précoces
- AdaptDx Selected to be Part of the MACUSTAR Study
- The Importance of Dark Adaptation Functional Testing for AMD
- Find AMD Even Before Clinical Signs Appear with the Help of AdaptDx
- Dark Adaptometry and Its Role in AMD Diagnosis
- A Passion for AMD Prevention
- Earlier AMD Diagnosis Improves Disease Management
- Night Vision Problems; Diagnose AMD at its Earliest Stage!
- Empowering AMD Patients with Early Diagnosis
- AdaptDx Helps Detect Early AMD
- AdaptDx empowers you to prevent blindness caused by AMD
- AdaptDx Helps Diagnose and Treat AMD
- Kirman Eye: Becoming An AMD Center of Excellence
- AdaptDx Saves Patients’ Vision and Increases Practice Performance
- AdaptDx Improves Care for Patients with AMD
- AdaptDx: Helping Fight AMD
- AdaptDx: Patient Value and Practice Value
- AdaptDx: The Path to Invention
- Vision Source; Blazing the Trail for AMD Management
- AMD – The Next Big Wave
- AMD Warning Signs
- AMD: Better Outcomes Start with You
- Case 1 of Disappearing Drusen
- Case 2 of Disappearing Drusen
- Meet Theia I Breakthrough Eye Care Technology
- Hope Describes What the AdaptDx Means to Patients
- Improving AMD Outcomes
- Achieving Success with AdaptDx Training
- AdaptDx Technology Changes AMD Outcomes
- Optometrists on AdaptDx
- Optometrists on AdaptDx 2
- Optometrists on AdaptDx 3
- Q&A with Cataract Surgeon Mark Pyfer 1
- Optometrists on AdaptDx 4
- Q&A with Cataract Surgeon Mark Pyfer 2
- Q&A with Cataract Surgeon Mark Pyfer 3
- Q&A with Cataract Surgeon Mark Pyfer 4
- RI: An Early Warning Sign for AMD
- Two Cases of Disappearing Drusen in Patients with AMD
- Using the AdaptDx to Identify and Monitor AMD
- What To Expect During the AdaptDx Tabletop Test
- AdaptDx Pro: What To Expect During the Test
- About AMD, Its Risk Factors, and First Symptoms
- Why Early Detection of AMD Matters to Us
- Patients Talk about Dark Adaptation Testing
- Education Center: Webinars & CE Opportunities
- For Patients
- Help
- Cookie Declaration
- Disclaimer
- Privacy Policy
- News
- Patents
- Contact us
- Theia’s Resume
- Gary VanMatre – Sales
- William D. McPhee
- Gregory R. Jackson
- Michael Fuchs
- Leah Jones
- Mark Ketcham
- Aaron Wood
- Todd Kuehn
- Hendrick Auguste
- Brian Driscoll
- Aaron Ducre
- Kenny Frye
- Ben Hand
- Andrea Higgins
- Ross Narucki
- Glenn Corbin
- Damon Dierker
- Jessica Rittenhouse
- Steven G. Ferrucci
- Bill Romeo
- Jeffry Gerson
- Tyler Rodrigues
- John Stephenson
- Justin VanMatre
- Paul Karpecki
- Gary Kirman
- Brandon Vrable
- Jennifer DelPrete
- Pamela Lowe
- Laura Walter
- Laurie Sorrenson
- Nolan Wilson
- Dixie Long
- Victoria Dzurinko
- Bonnie Stintsman
- Danielle Young
- Lisa Chatlain
- Heather Jones
- Matthew Mullen
- Ashley Macedo
- Dan Dorsey
- Dave Miller
- Stephen L. Rose
- Gary VanMatre
- Ronald P. Thiboutot
- Jack Nielsen, M.Sc.
- Nathan Dau